Neuroblastoma: biological insights into a clinical enigma

By G. Brodeur. Nature Reviews. Cancer, 2003

2,175 citations recorded by the source corpus.

Subfields: Cancer Research, Molecular Biology, Neurology

View Paper: https://www.semanticscholar.org/paper/48eb884166e0229c9bed73285bb068fc0002550e

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Cancer Research

1. J. Massagué
2. G. Gupta
3. G. Brodeur

In Molecular Biology

1. J. Massagué
2. D. Peeper
3. G. Gupta
4. G. Brodeur
5. R. Weinberg
6. A. Moustakas
7. C. Heldin
8. E. Batlle

In Neurology

1. J. Massagué
2. G. Gupta

Citations in the corpus

• The International Neuroblastoma Risk Group (INRG) classification system: an INRG Task Force report. (2009, background): “regressing or maturing, whereas others progress despite intensive multimodality treatment.(1,2) This di-”
• Suppression of anoikis and induction of metastasis by the neurotrophic receptor TrkB (2004, background): “TrkB and BDNF are frequently overexpressed in human cancer, including pancreatic and prostate carcinomas, Wilms' tumour and neuroblastomas, particularly those with aggressive behaviour and poor prognosi”
• Cancer metastasis: building a framework. (2006, background): “Pediatric neuroblastomas with evidence for genomic loss at the caspase 8 locus are commonly associated with a poor overall prognosis (Brodeur, 2003).”
• MicroRNA-34a functions as a potential tumor suppressor by inducing apoptosis in neuroblastoma cells (2007, background): “These tumors account for 15% of childhood cancer deaths and are particularly noted for a wide range in clinical behavior, ranging from spontaneous regression to rapid progression and death owing to disease (Brodeur, 2003).”